R&D Systems™ Recombinant Human NKG2A/CD159a Fc Chimera Protein

Catalog No.	Quantity
10511NK050	50 μg

Catalog No. 10511NK050 Supplier R&D Systems™ Supplier No. 10511NK050

Description

Measured by its binding ability in a functional ELISA. When Recombinant Human CD94 His-tag (Catalog # 9270-CD ) is immobilized at 2 μg/mL (100 μL/well), Recombinant Human NKG2A/CD159a Fc Chimera (Catalog # 10511-NK) binds with an ED50 of 2-16 μg/mL.

Specifications

• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 3821
• Molecular Weight (g/mol): M.W.-observed: 55-65 kDa, under reducing conditions, M.W.-theroretical: 43 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human NKG2A/CD159a protein MD Human IgG1 (Pro100-Lys330) IEGR Human NKG2A/CD159a (Pro94-Leu233) (c-terminus) Accession # P26715.2 N-terminus C-terminμs
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: CD159 antigen-like family member A, CD159a, CD159a antigen, C-lectin type II protein, killer cell lectin-like receptor subfamily C, member 1, Klrc1, MGC13374, natural killer cell lectin, natural killer group protein 2, NK cell receptor A, NKG2, NKG2-1/B activating NK receptor, NKG2-A, NKG2-A/B type II integral membrane protein, NKG2-A/B-activating NK receptor, NKG2-A/NKG2-B type II integral membrane protein, NKG2AMGC59791, NKG2-B
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: NKG2A/CD159a/KLRC1